Abstract:Mutations in either cubilin (CUBN) or amnionless (AMN) genes cause Imerslund–Gräsbeck syndrome (IGS), a hereditary disease characterised by anaemia attributed to selective intestinal malabsorption of cobalamin and low-molecular weight proteinuria. Although cubilin protein does not have a transmembrane segment, it functions as a multi-ligand receptor by binding to the transmembrane protein, amnionless. We established a system to quantitatively analyse membrane targeting of the protein complex in cultured renal … Show more
“…To confirm the expression of NUP93 in endothelial cells, double-staining with CD31, an endothelial marker, was performed, and revealed expression of NUP93 in endothelial cells both within and outside the glomeruli (Figure 2b, A, B, 1, and 2). For the renal tubules, we performed double-staining with NUP93 and amnionless, as a marker of proximal tubules, 33 and confirmed that NUP93 was expressed in the form of dots in the nuclei of the proximal tubules (Figure 2b, C, D, and 3)and distal tubules (Figure 2b, C, D, and 4) of the human kidney sections.…”
Introduction
Mutations in genes encoding nucleoporins (NUPs; components of nuclear pore complexes [NPCs]), such as
NUP93
, have been reported to cause steroid-resistant nephrotic syndrome (SRNS) or focal segmental glomerulosclerosis (FSGS), which often progresses to end-stage renal disease (ESRD) in childhood. The expression of NUP93 in renal or extrarenal tissues, and the mechanism by which
NUP93
mutations cause this renal phenotype, remain unclear.
Methods
The expression of NUP93 in normal control kidney and in a patient with FSGS carrying
NUP93
mutations was examined by immunofluorescence analysis. The expression of NUP93 in blood cells was analyzed by Western blot analysis.
Results
Immunofluorescence analysis detected NUP93 expression in nuclei of all glomerular and tubulointerstitial cells in human kidneys. Whole-exome sequencing identified a compound heterozygous
NUP93
mutation comprising a novel missense mutation p.Arg525Trp, and a previously reported mutation, p.Tyr629Cys, in a patient with FSGS that developed ESRD at the age of 6 years. In the patient’s kidney, the intensity of NUP93 immunofluorescence was significantly decreased in the nuclei of both glomerular and extraglomerular cells. The expression of CD2-associated protein (CD2AP) and nephrin in the patient’s podocytes was relatively intact. The amount of NUP93 protein was not significantly altered in the peripheral blood mononuclear cells of the patient.
Conclusion
NUP93 is expressed in the nuclei of all the cell types of the human kidney. Altered NUP93 expression in glomerular cells as well as extraglomerular cells by
NUP93
mutations may underlie the pathogenic mechanism of SRNS or FSGS.
“…To confirm the expression of NUP93 in endothelial cells, double-staining with CD31, an endothelial marker, was performed, and revealed expression of NUP93 in endothelial cells both within and outside the glomeruli (Figure 2b, A, B, 1, and 2). For the renal tubules, we performed double-staining with NUP93 and amnionless, as a marker of proximal tubules, 33 and confirmed that NUP93 was expressed in the form of dots in the nuclei of the proximal tubules (Figure 2b, C, D, and 3)and distal tubules (Figure 2b, C, D, and 4) of the human kidney sections.…”
Introduction
Mutations in genes encoding nucleoporins (NUPs; components of nuclear pore complexes [NPCs]), such as
NUP93
, have been reported to cause steroid-resistant nephrotic syndrome (SRNS) or focal segmental glomerulosclerosis (FSGS), which often progresses to end-stage renal disease (ESRD) in childhood. The expression of NUP93 in renal or extrarenal tissues, and the mechanism by which
NUP93
mutations cause this renal phenotype, remain unclear.
Methods
The expression of NUP93 in normal control kidney and in a patient with FSGS carrying
NUP93
mutations was examined by immunofluorescence analysis. The expression of NUP93 in blood cells was analyzed by Western blot analysis.
Results
Immunofluorescence analysis detected NUP93 expression in nuclei of all glomerular and tubulointerstitial cells in human kidneys. Whole-exome sequencing identified a compound heterozygous
NUP93
mutation comprising a novel missense mutation p.Arg525Trp, and a previously reported mutation, p.Tyr629Cys, in a patient with FSGS that developed ESRD at the age of 6 years. In the patient’s kidney, the intensity of NUP93 immunofluorescence was significantly decreased in the nuclei of both glomerular and extraglomerular cells. The expression of CD2-associated protein (CD2AP) and nephrin in the patient’s podocytes was relatively intact. The amount of NUP93 protein was not significantly altered in the peripheral blood mononuclear cells of the patient.
Conclusion
NUP93 is expressed in the nuclei of all the cell types of the human kidney. Altered NUP93 expression in glomerular cells as well as extraglomerular cells by
NUP93
mutations may underlie the pathogenic mechanism of SRNS or FSGS.
“…The AMN IGS mutations L59P 27 , M69K 31 , C234F 32 and G254E 27 are all retained in the ER when co-expressed with cubilin in HEK293 cells 16 , which explains why these mutations impair cubam receptor function and cause IGS. Introducing the individual mutations in our E. coli expression system does not yield any soluble AMN or AMN–cubilin complex (Supplementary Figure 5 ).…”
Section: Resultsmentioning
confidence: 99%
“…Cubam and megalin co-localise in the endocytic apparatus and appear to be functionally dependent on each other, at least in the kidney 43 , 44 . However, megalin is not required for cubam surface expression 16 and the fact that megalin seems less expressed in the intestine 45 suggests that cubam is capable of functioning independently of megalin. The extraordinary sizes of receptor ecto-domains in both megalin and cubam are remarkable and may be advantageous for optimal catching and endocytosis of multiple ligands from the extracellular fluids.…”
Section: Discussionmentioning
confidence: 99%
“…AMN is formed by an extracellular domain, a transmembrane helix and a short cytoplasmic domain harbouring two adaptor protein-2-binding signals (Phe-X-Asn-Pro-X-Phe) for ligand-independent internalisation in clathrin-coated pits 13 , 14 . As cubilin and AMN depend on each other for proper processing and translocation to the apical membrane, disrupted interaction of the two proteins leads to retention of both in the endoplasmic reticulum (ER) 13 , 15 , 16 . Accordingly, defects in the genes encoding either cubilin or AMN both give rise to IGS.…”
The endocytic receptor cubam formed by the 460-kDa protein cubilin and the 45-kDa transmembrane protein amnionless (AMN), is essential for intestinal vitamin B12 (B12) uptake and for protein (e.g. albumin) reabsorption from the kidney filtrate. Loss of function of any of the two components ultimately leads to serious B12 deficiency and urinary protein loss in humans (Imerslund-Gräsbeck’s syndrome, IGS). Here, we present the crystal structure of AMN in complex with the amino-terminal region of cubilin, revealing a sophisticated assembly of three cubilin subunits combining into a single intertwined β-helix domain that docks to a corresponding three-faced β-helix domain in AMN. This β-helix-β-helix association thereby anchors three ligand-binding cubilin subunits to the transmembrane AMN. Electron microscopy of full-length cubam reveals a 700–800 Å long tree-like structure with the potential of dimerization into an even larger complex. Furthermore, effects of known human mutations causing IGS are explained by the structural information.
“…The latter shows high expression in the distal intestinal tract and proximal renal tubules, and has important roles in the absorption of Cbl within the intestine and reabsorption of urinary protein in the kidney. Hence, a CUBN mutation on chromosome 10 and/or AMN on chromosome 14 can lead to IGS [ 18 – 20 ]. Genetic analyses of peripheral blood-derived DNA in Case 2 revealed two heterozygous variants of AMN , c.742C > T (p.Q248*, from his mother) and c.761G > A (p.G254E, from his father), in accordance with IGS.…”
Background
Disorders of the metabolism and absorption of vitamin B12 can lead to decrease in activity of methionine synthetase and methylmalonate coenzyme A mutase (MMUT), which results in increased levels of methylmalonic acid and homocysteine in blood and urine. Often, combined methylmalonic acidemia (MMA) and homocysteinemia is misdiagnosed due to a lack of specific symptoms. The clinical manifestations are diverse, but proteinuria as the initial presentation is rare.
Case presentation
Two cases of MMA with homocysteinemia in children are reported. Proteinuria were a primary presenting symptom, followed by anemia and neurologic symptoms (frequent convulsions and unstable walking, respectively). Screening of amino acids and acyl carnitine in serum showed that the propionyl carnitine:acetylcarnitine ratio increased. Profiling of urinary organic acids by gas chromatography–mass spectrometry revealed high levels of methylmalonic acid. Homocysteine content in blood was increased. Comprehensive genetic analyses of peripheral blood-derived DNA demonstrated heterozygous variants of methylmalonic aciduria type C and homocystinuria (MMACHC) and amnionless (AMN) genes in our two patients, respectively. After active treatment, the clinical manifestations in Case 1 were relieved and urinary protein ceased to be observed; Case 2 had persistent proteinuria and was lost to follow-up.
Conclusions
Analyses of the organic acids in blood and urine suggested MMA combined with homocysteinemia. In such diseases, reports of renal damage are uncommon and proteinuria as the initial presentation is rare. Molecular analysis indicated two different genetic causes. Although the pathologic mechanisms were related to vitamin B12, the severity and prognosis of renal lesions were different. Therefore, gene detection provides new insights into inherited metabolic diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.